Systematic review of immune checkpoint inhibitor-related gastrointestinal, hepatobiliary, and pancreatic adverse events.
Shatila M, Zhang HC, Shirwaikar Thomas A, Machado AP, Naz S, Mittal N, Catinis C, Varatharajalu K, Colli Cruz C, Lu E, Wu D, Brahmer JR, Carbonnel F, Hanauer SB, Lashner B, Schneider B, Thompson JA, Obeid M, Farris DP, Wang Y.
Shatila M, et al. Among authors: wu d.
J Immunother Cancer. 2024 Nov 14;12(11):e009742. doi: 10.1136/jitc-2024-009742.
J Immunother Cancer. 2024.
PMID: 39542654